BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16323214)

  • 1. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
    Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
    J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
    Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
    J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis.
    Andries M; Van Damme P; Robberecht W; Van Den Bosch L
    Neurobiol Dis; 2007 Jan; 25(1):8-16. PubMed ID: 17045808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice.
    Petri S; Schmalbach S; Grosskreutz J; Krampfl K; Grothe C; Dengler R; Van Den Bosch L; Robberecht W; Bufler J
    J Neurol Sci; 2005 Nov; 238(1-2):25-30. PubMed ID: 16087196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis.
    Patai R; Paizs M; Tortarolo M; Bendotti C; Obál I; Engelhardt JI; Siklós L
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1739-1748. PubMed ID: 28528135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit.
    Kuner R; Groom AJ; Müller G; Kornau HC; Stefovska V; Bresink I; Hartmann B; Tschauner K; Waibel S; Ludolph AC; Ikonomidou C; Seeburg PH; Turski L
    Ann N Y Acad Sci; 2005 Aug; 1053():269-86. PubMed ID: 16179532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.
    Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):605-12. PubMed ID: 16042312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and changes in neurotrophin receptor p75-Expressing motor neurons in SOD1(G93A) G1H mice [corrected].
    Smith KS; Rush RA; Rogers ML
    J Comp Neurol; 2015 Aug; 523(11):1664-82. PubMed ID: 25711805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit.
    Kuner R; Groom AJ; Bresink I; Kornau HC; Stefovska V; Müller G; Hartmann B; Tschauner K; Waibel S; Ludolph AC; Ikonomidou C; Seeburg PH; Turski L
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5826-31. PubMed ID: 15827116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.
    Sharp PS; Akbar MT; Bouri S; Senda A; Joshi K; Chen HJ; Latchman DS; Wells DJ; de Belleroche J
    Neurobiol Dis; 2008 Apr; 30(1):42-55. PubMed ID: 18255302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.
    Caioli S; Curcio L; Pieri M; Antonini A; Marolda R; Severini C; Zona C
    Neurobiol Dis; 2011 Oct; 44(1):92-101. PubMed ID: 21726643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
    Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice.
    Morrison BM; Janssen WG; Gordon JW; Morrison JH
    J Comp Neurol; 1998 Jun; 395(4):523-34. PubMed ID: 9619504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.